Super-Resolution Microscopy Patents: Who Leads, Where Gaps Are 2026
- Filing concentrated but not locked up. the top five assignees hold 27.5% of all 1,307 records in scope, and the top ten hold 38.8% — leaving a long tail of single- and few-filing entrants.
- Growth has cooled from its 2020 peak. filings ran 90 in 2017 and peaked at 120 in 2020; from 2021 (119) to 2024 (87), the last fully-published year, volume fell 27%.
- Imaging claims outnumber optics claims. G01N (material analysis & testing) touches 57.2% of records versus 31.5% for G02B (optical elements & systems), meaning the analytical and diagnostic layer is where the claim density actually sits.
Filing growth compares 2021 (119 records) with 2024 (87) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 1,307 records in scope (CR5), not by the ranked leaders only.
What the filing record shows
Super-resolution microscopy patenting spans optical hardware, image reconstruction and the diagnostic assays built on top of localization data. The search captures 1,307 patent families published between 2015 and mid-2026, drawing on techniques including single-molecule localization and stimulated emission depletion, combined with the practical bottlenecks that determine whether a method works outside a lab bench: localization precision, photoswitching buffers, drift correction, labelling density and phototoxicity. That combination of core technique and applied constraint is deliberate — it is where the commercially relevant claims tend to sit, rather than in the underlying optical principle alone.
Filing activity rose through the late 2010s, peaked in 2020, and has since eased off from that high, though the most recent years are still filling in as publications lag filing by roughly eighteen months. The assignee base includes a mix of academic institutions, instrument makers and diagnostics companies, with a small number of entities accounting for a disproportionate share of the record — a pattern worth checking before committing to a filing strategy in any single sub-area.
Filing trends and technology composition
Two views of the same 1,307-record dataset: how filing volume has moved year over year, and how those records distribute across IPC subclasses.
Filing trend, 2017-2026
Filings climbed from 90 in 2017 to a peak of 120 in 2020, then eased to 87 by 2024 — a 27% decline over the 2021-2024 span. 2025 and 2026 figures are understated because publication typically lags filing by around 18 months.
Technology composition by IPC subclass
G01N (material analysis & testing) appears in 57.2% of the 1,307 records, ahead of G02B (optical elements & systems) at 31.5% and C12Q (enzyme/DNA-related measuring) at 27.5%. Because records can carry multiple IPC codes, these shares sum to well over 100% and should be read individually against the full record total, not against each other.
Shares are the percentage of the 1,307 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Super-Resolution Microscopy with Eureka
This page is one run against one query. Ask Eureka your own question about super-resolution microscopy and every answer comes back with the patent numbers behind it.
Try EurekaRepresentative and most-cited filings
US11676247B2 — Reconstruction of dense super-resolution images from single molecule localization microscopy
The patent covers reconstructing a synthetic dense super-resolution image from a sequence of diffraction-limited images acquired by single molecule localization microscopy. A sparse localization image is first reconstructed using standard SMLM processing, then fed — alone or alongside a low-resolution wide-field image — into an artificial neural network that outputs the synthetic dense image.Filed by Institut Pasteur; published 2023-06-13.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20070057211A1 | Multifocal imaging systems and method | 338 |
| 2 | US20160327779A1 | Systems And Methods for Three Dimensional Imaging | 329 |
| 3 | US8435738B2 | Systems and methods for multi-analysis | 312 |
| 4 | US20170220733A1 | Systems and methods for determining nucleic acids | 296 |
| 5 | US20050244863A1 | Molecular arrays and single molecule detection | 270 |
| 6 | US20140234949A1 | Systems and methods for fluid and component handling | 263 |
| 7 | US20130078624A1 | Systems and methods for multi-purpose analysis | 263 |
| 8 | US20140296089A1 | Systems and methods for multi-analysis | 256 |
| 9 | US20190333199A1 | Systems and methods for deep learning microscopy | 254 |
| 10 | WO2013052318A1 | Systems and methods for multi-analysis | 249 |
Citation counts reflect accumulated influence within the searched corpus and favour older filings; treat them as a signal of historical impact rather than current commercial weight.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns stand out once volume, concentration and claim topic are read together.
The top of the field is dense, the rest is open
The five most active assignees account for 27.5% of all records and the top ten for 38.8%. That leaves roughly six in ten records spread across the other ranked assignees and unranked filers, which is a wide base for a new entrant to find adjacent, unblocked claim territory rather than competing head-on with the leaders.
Volume has pulled back from its 2020 peak
Filings rose steadily to 120 in 2020 before easing to 87 by 2024, a 27% decline over that three-year window. This reads as a maturing claim space rather than a collapsing one — the foundational optical and reconstruction techniques are largely staked out, and later filings increasingly target specific assay or diagnostic applications.
The analytical layer, not just the optics, is where claims concentrate
G01N (material analysis & testing) appears in more than half of all records, well ahead of G02B optical systems at 31.5% and C12Q enzyme/DNA measurement at 27.5%. Filers are patenting what the microscopy enables — assays, diagnostics, molecular detection — at least as heavily as the imaging hardware itself.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to super-resolution microscopy, with the prior art for and against each one.
Who is filing, and where the activity has cooled
The ranking spans 100 assignees drawn from academia, instrument makers and diagnostics firms. Recent-year momentum data shows several previously active filers dropping to zero in the latest tracked year — a pattern consistent with the broader post-2020 pullback rather than any single company's retreat.
A single assignee well ahead of the field
The top-ranked assignee holds 152 records, notably ahead of the fifth-place holder at 40 and tenth place at 24 — a steep drop-off after the leader rather than a gradual taper.
A quick fall-off after the leader
Fifth place holds 40 records and tenth place 24, meaning the gap between the leader and the rest of the top ten is far larger than the gaps within the top ten itself.
Co-filing is limited and clustered
Only ten co-assignee pairs appear in the dataset, and the strongest links sit within related corporate or institutional families rather than across unrelated organisations — collaborative filing is the exception here, not the norm.
| Assignee | Recent year | YoY |
|---|---|---|
| Abberior Instruments GmbH | 1 | — |
| President & Fellows of Harvard College | 0 | -100% |
| Theranos, Inc. | 0 | — |
| BioAxial SAS | 0 | -100% |
| Element Biosciences, Inc. | 0 | -100% |
| Max Planck Gesellschaft zur Foerderung der Wissenschaften e.V. | 0 | -100% |
| xGenomes Corp | 0 | — |
| The Regents of the University of Michigan | 0 | — |
Turning this landscape into a filing or freedom-to-operate position
The dataset points to where claim density sits and where it thins out. Turning that into a decision — file, design around, or license — takes a closer read of the specific claims involved.
Check freedom-to-operate against the leader's portfolio
With 152 records versus 40 at fifth place, the top assignee's claim scope deserves a direct check before committing engineering resources to overlapping approaches.
Run a freedom-to-operate check in EurekaExplore the under-claimed branches directly
Drift correction, photoswitching chemistry and labelling density optimisation show up across the dataset but without a dominant assignee — a reasonable place to look for open claim territory.
Explore white space in EurekaTrack momentum, not just headcount
Several previously active filers show zero activity in the latest tracked year; distinguishing a genuine pullback from a publication-lag artefact matters for competitive monitoring.
Set up assignee tracking in EurekaCommon questions about super-resolution microscopy patents
This dataset identifies 1,307 patent families published between 2015 and mid-2026 that combine core super-resolution techniques, such as single-molecule localization and stimulated emission depletion, with practical implementation constraints like localization precision, drift correction and labelling density. The true global figure will be higher, since any keyword-based search has boundaries, but 1,307 gives a workable sense of scale. Because publication lags filing by roughly 18 months, the 2025-2026 counts in particular will rise as more applications publish.
The ranking covers 100 assignees, with the leader holding 152 records against 40 at fifth place and 24 at tenth — a steep drop after the top filer rather than a gradual taper. The top five assignees combined account for 27.5% of all 1,307 records, and the top ten for 38.8%, so a majority of the filing activity sits outside this concentrated group. The assignee base mixes academic institutions, microscope and instrument makers, and diagnostics companies.
Filing volume rose from 90 records in 2017 to a peak of 120 in 2020, then declined to 87 by 2024 — a 27% drop over that three-year span, which is the last period with reasonably complete publication data. This looks more like a maturing core technology than a shrinking field: the foundational optical and reconstruction methods are heavily claimed, pushing new filings toward specific applications. Figures for 2025 onward are still incomplete due to the normal filing-to-publication lag.
Relative to the dense claim coverage in material analysis (G01N, 57.2% of records) and optical systems (G02B, 31.5%), areas such as drift correction algorithms, photoswitching buffer chemistry, labelling density optimisation for dense samples, and bioinformatics pipelines for localization data (G16B, 6.3%) carry noticeably lighter claim density. These are reasonable starting points for scouting first-claim opportunities, though each requires its own prior-art check rather than relying on IPC share alone.
US11676247B2, held by Institut Pasteur and published in 2023, covers reconstructing a synthetic dense super-resolution image from diffraction-limited image sequences using a two-stage process: a standard single-molecule localization reconstruction followed by an artificial neural network step. It blocks that specific combination of SMLM localization output feeding into a neural network for dense image synthesis. It does not, on its face, block other reconstruction approaches that skip the neural network step or use different input combinations, so a design-around is plausible but should be checked claim-by-claim.
Research Super-Resolution Microscopy in depth with Eureka
Go past this page: query the whole super-resolution microscopy corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.